h-index: 18     i10-index: 25

A Basic Strategic Approach for Method Development by Inductively Coupled Plasma Mass Spectrometry (ICP-MS): A Review

Document Type : Review Article

Authors

1 Department of Pharmaceutical Quality Assurance, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India

2 Department of Pharmaceutics, Government Pharmacy College, Gandhinagar, Gujarat, India

3 Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India

Abstract
Method development for ICP-MS entails optimizing parameters to ensure precise and accurate elemental measurements. Sample preparation involves selecting techniques like digestion and dilution. Instrument setup optimizes plasma power and calibration with certified reference materials. Mass selection considers sensitivity and interference. Background correction methods account for spectral interferences. Internal standards correct for variations. Quality control ensures accuracy through replicate analyses and spike recoveries. Data analysis involves quantification and validation based on regulatory guidelines. Method optimization refines parameters for improved sensitivity and robustness. Comprehensive documentation and SOPs maintain consistency. Validation assesses accuracy, precision, and linearity according to standards like USP and ICH. Overall, this systematic approach guarantees reliable elemental analysis using ICP-MS.

Keywords


OPEN ACCESS

©2024 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

[1]. United States Pharmacopeia and National Formulary (USP 42-NF 37), Chapter <232>, Elemental Impurities-Limits. [Publisher]
[2]. ICH guidance for industry, Q3D(R1) Guideline for Elemental Impurities. [Publisher]
[3]. S.J. Hill, Inductively coupled plasma spectrometry and its applications, John Wiley & Sons, 2008. [Google Scholar], [Publisher]
[4]. C. Jin, Clean chemistry for elemental impurities analysis of pharmaceuticals in compliance with USP 232, AAPS PharmSciTech, 2016, 17, 1141-1149. [Crossref], [Google Scholar], [Publisher]
[5]. M. Cassap, Using ICP-MS and ICP-OES to measure trace elemental impurities in pharmaceuticals in compliance with proposed pharmacopeia chapters, Spectroscopy, 2011, 26, 26-29. [Google Scholar], [Publisher]
[6]. J.S. Barin, P.A. Mello, M.F. Mesko, F.A. Duarte, E.M. Flores, Determination of elemental impurities in pharmaceutical products and related matrices by ICP-based methods: a review, Analytical and Bioanalytical Chemistry, 2016, 408, 4547-4566. [Crossref], [Google Scholar], [Publisher]
[7]. D. Beauchemin, Inductively coupled plasma mass spectrometry, Analytical Chemistry, 2008, 80, 4455-4486. [Crossref], [Google Scholar], [Publisher]
[8]. United States Pharmacopeia and National Formulary (USP 40-NF 35). Chapter <231>, Heavy metals. [Google Scholar]
[9]. T. Pluháček, M. Ručka, V. Maier, A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D, Analytica Chimica Acta, 2019, 1078, 1-7. [Crossref], [Google Scholar], [Publisher]
[10]. F.C. Pinheiro, J.A. Nobrega, An overview of sample preparation procedures for determination of elemental impurities in medicines, Microchemical Journal, 2022, 175, 107189. [Crossref], [Google Scholar], [Publisher]
[11]. M. Cassap, Using ICP-MS and ICP-OES to measure trace elemental impurities in pharmaceuticals in compliance with proposed pharmacopeia chapters, Spectroscopy, 2011, 26, 26-29. [Google Scholar], [Publisher]
[12]. United States Pharmacopeia and National Formulary (USP 42-NF 37), Chapter <233>, Elemental Impurities — Procedures.
[13].  G. Li, D. Schoneker, K.L. Ulman, J.J. Sturm, L.M. Thackery, J.F. Kauffman, Elemental impurities in pharmaceutical excipients, Journal of Pharmaceutical Sciences, 2015, 104, 4197-4206. [Crossref], [Google Scholar], [Publisher] [14]. S.C. Wilschefski, M.R. Baxter, inductively coupled plasma mass spectrometry: introduction to analytical aspects, The Clinical Biochemist Reviews, 2019, 40, 115. [Crossref], [Google Scholar], [Publisher]
[15]. M.F. Al-Hakkani, Guideline of inductively coupled plasma mass spectrometry “ICP–MS”: Fundamentals, practices, determination of the limits, quality control, and method validation parameters, SN Applied Sciences, 2019, 1, 791. [Crossref], [Google Scholar], [Publisher]
[16]. A.B. Patel, A.R. Bundheliya, A.J. Vyas, N.K. Patel, A.I. Patel, A.N. Lumbhani, A review on metal impurities in pharmaceuticals, Asian Journal of Pharmaceutical Analysis, 2021, 11, 212-222. [Crossref], [Google Scholar], [Publisher]
[17]. A.I. Patel, A.K. Mandavia, A.J. Vyas, A.B. Patel, Nitrosamine impurity: Management of unwelcome guest in pharma market, Asian Journal of Pharmaceutical Analysis, 2023, 13, 303-308. [Crossref], [Google Scholar], [Publisher]
[18]. M. Rajput, N. Patel, U. Chotaliya, A. Patel, A. Patel, A. Vyas, Determination of genotoxic impurity by chromatographic method, Pharma Sci Monit, 2017, 8, 24-31. [Google Scholar], [Publisher]
[19]. A.B. Patel, A.H. Asnani, A.J. Vyas, N.K. Patel, A.I. Patel, D.A.N. Lumbhani, A brief review on genotoxic impurities in pharmaceuticals, Asian Journal of Pharmaceutical Research, 2021, 11, 187-193. [Crossref], [Google Scholar], [Publisher]
[20]. R.S. Pappas, Sample preparation problem solving for inductively coupled plasma-mass spectrometry with liquid introduction systems I. Solubility, chelation, and memory effects, Spectroscopy (Springfield, Or.), 2012, 27, 20. [Google Scholar], [Publisher]
[21]. D. Kutscher, J. Cui, C. Cojocariu, Key Steps to Create a Sample Preparation Strategy for Inductively Coupled Plasma (ICP) or ICP–Mass Spectrometry (ICP-MS) Analysis, 2022. [Crossref], [Google Scholar], [Publisher]
[22]. E.d. Oliveira, Sample preparation for atomic spectroscopy: evolution and future trends, Journal of the Brazilian Chemical Society, 2003, 14, 174-182. [Crossref], [Google Scholar], [Publisher]
[23]. H. Matusiewicz, Sample preparation for inorganic trace element analysis, Physical Sciences Reviews, 2017, 2, 20178001. [Crossref], [Google Scholar], [Publisher]
[24]. M. Aramendía, J.C. García-Mesa, E.V. Alonso, R. Garde, A. Bazo, J. Resano, M. Resano, A novel approach for adapting the standard addition method to single particle-ICP-MS for the accurate determination of NP size and number concentration in complex matrices, Analytica Chimica Acta, 2022, 1205, 339738. [Crossref], [Google Scholar], [Publisher]
[25]. D. Beauchemin, Sample introduction systems in ICPMS and ICPOES, Newnes, 2020. [Google Scholar], [Publisher]
[26]. J.A. Carter, A.I. Barros, J.A. Nóbrega, G.L. Donati, Traditional calibration methods in atomic spectrometry and new calibration strategies for inductively coupled plasma mass spectrometry, Frontiers in Chemistry, 2018, 6, 504. [Crossref], [Google Scholar], [Publisher]
[27]. L. Dussubieux, M.A. Hill, G.D. Lattanzi, Comparison of different sets of external standards for the LA-ICP-MS analysis of North American copper artifacts, Journal of Archaeological Science: Reports, 2019, 24, 1076-1082. [Crossref], [Google Scholar], [Publisher]
[28]. M.M. Cheatham, W.F. Sangrey, W.M. White, Sources of error in external calibration ICP-MS analysis of geological samples and an improved non-linear drift correction procedure, Spectrochimica Acta Part B: Atomic Spectroscopy, 1993, 48, 487-506. [Crossref], [Google Scholar], [Publisher]
[29]. A. Vesterlund, H. Ramebäck, Achieving confidence in trace element analysis for nuclear forensic purposes: ICP-MS measurements using external calibration, Journal of Radioanalytical and Nuclear Chemistry, 2019, 322, 941-948. [Crossref], [Google Scholar], [Publisher]
[30]. E. Bulska, B. Wagner, Quantitative aspects of inductively coupled plasma mass spectrometry, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2016, 374, 20150369. [Crossref], [Google Scholar], [Publisher]
[31]. F. Vanhaecke, H. Vanhoe, R. Dams, C. Vandecasteele, The use of internal standards in ICP-MS, Talanta, 1992, 39, 737-742. [Crossref], [Google Scholar], [Publisher]
[32]. R.S. Houk, J.J. Thompson, Inductively coupled plasma mass spectrometry, Mass Spectrometry Reviews, 1988, 7, 425-461. [Crossref], [Google Scholar], [Publisher]
[33]. C.A. Georgiou, G.P. Danezis, Elemental and isotopic mass spectrometry, Comprehensive analytical chemistry, Elsevier, 2015, 68, 131-243. [Crossref], [Google Scholar], [Publisher]
[34]. V. Balaram, Strategies to overcome interferences in elemental and isotopic geochemical analysis by quadrupole inductively coupled plasma mass spectrometry: A critical evaluation of the recent developments, Rapid Communications in Mass Spectrometry, 2021, 35, e9065. [Crossref], [Google Scholar], [Publisher]
[35]. S. D’Ilio, F. Petrucci, O. Senofonte, N. Violante, Study of oxide-based interferences on trace elements determination in ICP-MS, Handbook on mass spectrometry: instrumentation, data and analysis, and applications, Nova Science Publishers, Inc., New York, 2009, 201-224. [Google Scholar]
[36]. V. Balaram, Strategies to overcome interferences in elemental and isotopic geochemical analysis by quadrupole inductively coupled plasma mass spectrometry: A critical evaluation of the recent developments, Rapid Communications in Mass Spectrometry, 2021, 35, e9065. [Crossref], [Google Scholar], [Publisher]
[37]. O. Chahrour, J. Malone, M. Collins, V. Salmon, C. Greenan, A. Bombardier, Z. Ma, N. Dunwoody, Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP< 232>/< 233, Journal of Pharmaceutical and Biomedical Analysis, 2017, 145, 84-90. [Crossref], [Google Scholar], [Publisher]
[38]. P. Pohl, A. Bielawska-Pohl, A. Dzimitrowicz, P. Jamroz, M. Welna, Impact and practicability of recently introduced requirements on elemental impurities, TrAC Trends in Analytical Chemistry, 2018, 101, 43-55. [Crossref], [Google Scholar], [Publisher]
[39]. V. Balaram, Recent advances in the determination of elemental impurities in pharmaceuticals–Status, challenges and moving frontiers, Trac trends in Analytical chemistry, 2016, 80, 83-95. [Google Scholar], [Publisher]
[40]. United States Pharmacopeia and National Formulary (USP 38-NF 33). Chapter <1730>, Plasma Spectrochemistry -Theory and Practice. [Google Scholar]
[41]. F.C. Pinheiro, A.I. Barros, J.A. Nóbrega, Microwave-assisted sample preparation of medicines for determination of elemental impurities in compliance with United States Pharmacopeia: How simple can it be?, Analytica Chimica Acta, 2019, 1065, 1-11. [Crossref], [Google Scholar], [Publisher]
[42]. R.N. Rao, M.K. Talluri, An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals, Journal of Pharmaceutical and Biomedical Analysis, 2007, 43, 1-13. [Crossref], [Google Scholar], [Publisher]
[43]. United States Pharmacopeia and National Formulary (USP 42-NF 37), Chapter <730>, Plasma Spectrochemistry. [Google Scholar]
[44]. United States Pharmacopeia and National Formulary (USP 42-NF 37), Chapter <736>, Mass Spectrometry. [Google Scholar]
[45]. M.E.Mohammadi-Arani, R. Zibaseresht, M. Chamanara, R. Mosaed, M. Mahboubi-Rabbani, M. Bayanati, H.Fasihi, A review of HPLC methods developed for quantitative analysis of carbamazepine in plasma samples, Journal of Chemical Reviews, 2024, 6, 76-93. [Crossref], [Publisher]
[46]. S. Maghsoudi, S. Hosseini, S. Ravandi, A review on phospholipid and liposome carriers: synthetic methods and their applications in drug delivery, Journal of Chemical Reviews, 2022, 4, 346-363. [Crossref], [Google Scholar], [Publisher]
 
Volume 5, Issue 1
Winter 2024
Pages 42-51

  • Receive Date 01 May 2024
  • Revise Date 30 May 2024
  • Accept Date 20 June 2024